Medications for Hormone Receptor Positive Breast Cancer

2 results

  • afinitor - everolimus tablet

    (Everolimus)
    Novartis Pharmaceuticals Corporation
    Afinitor treats postmenopausal women with advanced HR-positive, HER2-negative breast cancer; adults with progressive neuroendocrine tumors or advanced renal cell carcinoma; and tuberous sclerosis complex-related renal angiomyolipoma, SEGA, and partial-onset seizures (ages 2+).
    Medication Details
    Drug Interactions

  • faslodex - fulvestrant injection

    (Fulvestrant)
    Astrazeneca Pharmaceuticals Lp
    FASLODEX treats HR-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women. Used as monotherapy (treatment-naive or after endocrine therapy) or combined with ribociclib, palbociclib, or abemaciclib following disease progression on endocrine therapy.
    Medication Details
    Drug Interactions